ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MDNA Medicenna Therapeutics Corporation

0,157
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Medicenna Therapeutics Corporation MDNA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,157 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,157
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202421:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.4.202421:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25.4.202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.4.202422:40EDGAR2Form AW - Amendment Withdrawal Request
16.4.202423:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
16.4.202423:05EDGAR2Form F-3/A - Registration statement by foreign private..
16.4.202423:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
09.4.202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.4.202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.2.202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24.1.202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09.1.202416:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.1.202415:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.12.202320:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09.11.202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
08.11.202316:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.11.202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03.11.202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27.10.202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25.10.202321:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25.10.202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24.10.202313:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24.10.202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10.10.202314:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.10.202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03.10.202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.10.202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28.9.202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.9.202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28.9.202316:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.9.202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06.9.202313:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.9.202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28.8.202322:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.8.202322:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.8.202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14.8.202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.8.202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
09.8.202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.8.202315:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.8.202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04.8.202314:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.8.202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01.8.202318:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.8.202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28.7.202314:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.7.202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25.7.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25.7.202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
06.7.202316:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock